If you check the summary page for Amyris Inc. (AMRS) at GuruFocus, you'll find a lot of weak metrics. That includes ratings of 1 out of 10 for both financial strength and profitability. Obviously, this is a stock we should avoid.

Or should we? What we have here is an early-stage tech company that threatens to become a major disruptor.

About Amyris

Based in Emeryville, California, this $5.11 billion company was founded in 2003 and began publicly trading in 2010.

It specializes in synthetic biology. By way of explanation, the company reported in its 10-K for 2020 the example of

The stock of Procter & Gamble Co (NYSE:PG, 30-year Financials) gives every indication of being modestly overvalued, according to GuruFocus Value calculation. GuruFocus Value is GuruFocus' estimate of the fair value at which the stock should be traded. It is calculated based on the historical multiples that the stock has traded at, the past business growth and analyst estimates of future business performance. If the price of a stock is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the

• New Purchases: HUYA, SYY, SCHW, VTRS, NNN, HIW,

If you are seeking investment opportunities among U.S.-listed equities, you may want to consider the stocks listed below, as they have grown their free cash flow (FCF) remarkably over recent years. This should allow them more flexibility for financing the development of projects and returning cash to shareholders.

Wall Street also projects a rosy future for these stocks, as sell-side analysts have issued optimistic ratings for them.

Microsoft Corp

The first company investors should consider is Microsoft Corp (MSFT), a Redmond, Washington-based developer, manufacturer, licensor and seller of computer software, personal computers and consumer electronics.

The below table shows

According to the GuruFocus All-in-One Screener as of March 22, the following defensive stocks are popular among gurus.

Walmart

Walmart Inc. (WMT) has a market cap of $374.26 billion. Its revenue has grown 2.20% over the past 10 years.

The retailer is held by 17 gurus, including Ken Fisher (Trades, Portfolio) with 0.42% of outstanding shares, followed by Bill Gates (Trades, Portfolio)' foundation trust with 0.41% and Ray Dalio (Trades, Portfolio) with 0.11%.

As of March 22, shares were trading with a price-earnings ratio

There's little doubt that The Clorox Co. (CLX) will see its growth slow down as the Covid-19 pandemic recedes. Does that mean this cleaning products company is no longer a good investment?

That seems unlikely, in my opinion. With a couple of exceptions, the share price has risen relatively steadily for the past 30 of its more than 100 years of existence:

About Clorox

As a result of the Covid-19 pandemic, there are now few investors who haven't become more familiar with Clorox, the bleach company. But bleach is just one of

The decline of the Covid-19 pandemic could ease the short-term demand spike for Clorox Co. (CLX) cleaning and disinfecting products, which will likely cause a drop in the stock price. However, I do not believe this will hurt the longer-term run-up in either demand for the company's products or its share prices.

Over the past year, Clorox has been in the right market segment of the consumer industry at the right time: cleaning and disinfecting products. Business is so good that the company is striving to catch up with demand by adding capacity and hiring third-party manufacturers.

Over

According to current portfolio statistics, the top four holdings of Nelson Peltz (Trades, Portfolio)'s Trian Fund Management as of the fourth quarter of 2020 are in Sysco Corp. (SYY), Proctor & Gamble Co. (PG), Comcast Corp. (CMCSA) and Mondelez International Inc. (MDLZ).

Peltz, board chairman of The Wendy's Co. (WEN), co-founded the New York-based investment management firm in 2005 with his business partners Peter May and Edward Green. The firm seeks long-term capital appreciation by investing in public equity and alternative investment markets through fundamental analysis and identification of undervalued securities.